Profile: Dr. Yiquan Jiang has long been engaged in clinical and translational research of interventional oncology and comprehensive cancer treatment. He is proficient in various minimally invasive interventional techniques for cancer treatment. He has published several SCI papers, such as in OncoImmunology, Journal of Cancer Research and Clinical Oncology in 2021, which have been cited for a total of 160 times. He is skilled in molecular biology experiments, animal experiments, bioinformatics analysis, data mining algorithms. In recent years, he has been dedicated to studying the functions and regulatory mechanisms of MDSCs in the tumor microenvironment. He participated in the National Natural Science Foundation of China Joint Fund project "The Key Role and Mechanism of MDSC in the Recurrence of Hepatocellular Carcinoma After Thermal Ablation". He is also the principal investigator of one Guangdong Provincial Collaborative Fund project "Mechanism of Myeloid-Derived Suppressor Cells Recruitment by Senescent Cells in Anthracycline Resistance of Triple Negative Breast Cancer".

Oncoimmunology, Minimally Invasive Interventional Therapy

2011-2019: M.D. in Clinical Medicine (8-year program), Sun Yat-sen University

2019-2021: Postdoctoral fellow, Sun Yat-sen University Cancer Center

1.Jiang Y-Q, Wang Z-X, Zhong M, Shen L-J, Han X, Zou X, et al. Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data. OncoImmunology 2021, 10(1): 1908010.

2.Jiang Y-Q, Cao S-E, Cao S, Chen J-N, Wang G-Y, Shi W-Q, et al. Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning. Journal of Cancer Research and Clinical Oncology 2021, 147(3): 821-833.

Updated by International Office, Sun Yat-sen University Cancer Center